Terms: = Head and neck cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
203 results:
1. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract] [Full Text] [Related]
2. HSP90B1 regulates autophagy
Li C; Lin X; Su J
PeerJ; 2024; 12():e17028. PubMed ID: 38590708
[TBL] [Abstract] [Full Text] [Related]
3. PQR309, a dual PI3K/mtor inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma.
Cao J; Zeng K; Chen Q; Yang T; Lu F; Lin C; Zhan J; Ma W; Zhou T; Huang Y; Luo F; Zhao H
Cell Death Dis; 2024 Mar; 15(3):237. PubMed ID: 38555280
[TBL] [Abstract] [Full Text] [Related]
4. Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.
Jagadeeshan S; Suryamohan K; Shin N; Mathukkada S; Boyko A; Melikhova D; Tsareva A; Yunusova L; Pravdivtseva E; Stupichev D; Shaposhnikov K; Peterson A; Bednyagin L; Shugaev-Mendosa E; Kessler L; Burrows F; Ho AL; Agrawal N; Pearson AT; Izumchenko E; Cole G; Elkabets M; Rosenberg AJ
Oral Oncol; 2024 Feb; 149():106688. PubMed ID: 38219706
[TBL] [Abstract] [Full Text] [Related]
5. Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways.
Doghish AS; El-Husseiny AA; Khidr EG; Elrebehy MA; Elballal MS; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Khaled R; El-Dakroury WA; Noureldin S; Moustafa YM; Mangoura SA; Gedawy EM; Abulsoud AI
Pathol Res Pract; 2023 Dec; 252():154949. PubMed ID: 37992507
[TBL] [Abstract] [Full Text] [Related]
6. The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer.
Wang LL; Li J; Xue H; Zhang L; Yu DY; Yang N; Yun WJ; Zhao MZ; Xue H
Histol Histopathol; 2024 May; 39(5):659-670. PubMed ID: 37982578
[TBL] [Abstract] [Full Text] [Related]
7. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mtor pathway.
Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
9. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Xin Y; Jiang Q; Liu C; Qiu J
Aging (Albany NY); 2023 Nov; 15(21):12225-12250. PubMed ID: 37925175
[TBL] [Abstract] [Full Text] [Related]
10. Signaling Pathways mtor and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma.
Codina-Martínez H; Lorenzo-Guerra SL; Cabal VN; García-Marín R; Suárez-Fernández L; Vivanco B; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894790
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
Wu M; Yuan H; Zou W; Xu S; Liu S; Gao Q; Guo Q; Han Y; An X
Clin Transl Oncol; 2024 Apr; 26(4):808-824. PubMed ID: 37864677
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-induced tumor exosomes promote angiogenesis through miR-1825/TSC2/mtor axis in oral squamous cell carcinoma.
Capik O; Gumus R; Karatas OF
Head Neck; 2023 Sep; 45(9):2259-2273. PubMed ID: 37449548
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
[TBL] [Abstract] [Full Text] [Related]
14. A Comprehensive Pan-cancer Analysis of the Potential Biological Functions and prognosis Values of RICTOR.
Sun Y; Li R; Nong B; Songyang Z; Wang X; Ma W; Zhou Q
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372460
[TBL] [Abstract] [Full Text] [Related]
15. TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway.
Wu W; Xu J; Gao D; Xie Z; Chen W; Li W; Yuan Q; Duan L; Zhang Y; Yang X; Chen Y; Dong Z; Liu K; Jiang Y
Cell Death Dis; 2023 Jun; 14(6):364. PubMed ID: 37328464
[TBL] [Abstract] [Full Text] [Related]
16. CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating ERBB2 via sponging miR-940.
Mo H; Shen J; Zhong Y; Chen Z; Wu T; Lv Y; Xie Y; Hao Y
Oncol Res; 2022; 30(4):187-199. PubMed ID: 37304410
[TBL] [Abstract] [Full Text] [Related]
17. Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor.
Zheng Y; Sang M; Liu F; Gu L; Li J; Wu Y; Shan B
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203393
[TBL] [Abstract] [Full Text] [Related]
18. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
Hegazy M; Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Abdelghany TM; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Doghish AS
Pathol Res Pract; 2023 Jun; 246():154510. PubMed ID: 37167812
[TBL] [Abstract] [Full Text] [Related]
19. Expression and Clinical Significance of Golgi Phosphoprotein 3 (GOLPH3) in Papillary Thyroid Carcinoma.
Yu WS; Zhou ZP; Zeng JF; Huang ZQ; Qiu CZ
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):324-330. PubMed ID: 36952588
[TBL] [Abstract] [Full Text] [Related]
20. Machilin D Promotes Apoptosis and Autophagy, and Inhibits Necroptosis in Human Oral Squamous Cell Carcinoma Cells.
Yun HM; Kwon YJ; Kim E; Chung HJ; Park KR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902006
[TBL] [Abstract] [Full Text] [Related]
[Next]
